ER, PR, and Her2 immunocytochemistry on cell-transferred cytologic smears of primary and metastatic breast carcinomas: A Comparison Study With Formalin-Fixed Cell Blocks and Surgical Biopsies

被引:23
作者
Ferguson, Jill [1 ]
Chamberlain, Pierce [1 ]
Cramer, Harvey M. [1 ]
Wu, Howard H. [1 ]
机构
[1] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA
关键词
estrogen receptor; progesterone receptor; HER2; immunohistochemistry; cell transfer; cytology; cell block; immunocytochemistry; COMMONLY USED IMMUNOSTAINS; ESTROGEN-RECEPTOR; CANCER; VALIDATION; SPECIMENS;
D O I
10.1002/dc.22897
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The use of formalin-fixed cell blocks (CBs) for detection of ER, PR, and Her2 status of primary and metastatic breast carcinomas sampled by fine-needle aspiration (FNA) has been extensively used in clinical practice; however, CBs sometimes lack adequate cellularity even when direct smears are cellular. The aim of this study is to assess the reliability of ER, PR, and Her2 status as demonstrated by immunocytochemical staining (ICC) on alcohol-fixed direct smears using the cell transfer (CT) technique. FNA cases diagnosed as primary or metastatic breast carcinoma in which the status of ER, PR, and Her2 had been determined either on CB or concurrent biopsy were identified over a period of 18 months. ICC for ER, PR, and Her2 was performed on alcohol-fixed direct smears using the CT technique. Results were compared with those reported for the corresponding formalin-fixed tissue. A total of 47 FNA specimens from 46 patients were included in this study. ICC results were excluded from analysis if the CT smear contained fewer than 50 cells. Correlation between the ICC performed on the CT smears and the corresponding CB or biopsy revealed a sensitivity rate for ER, PR, and Her2 of 95%, 90%, and 88%, respectively with a specificity of 100% for all three markers. ICC performed on the FNA smears using the CT technique is a reliable method for assessment of the ER, PR, and Her2 status of breast carcinomas, especially when the direct smears are highly cellular and the CB lacks adequate cellularity. Diagn. Cytopathol. 2013. (c) 2012 Wiley Periodicals, Inc.
引用
收藏
页码:575 / 581
页数:7
相关论文
共 16 条
[1]   HER-2/neu detection in fine-needle aspirates of breast cancer - Fluorescence in situ hybridization and immunocytochemical analysis [J].
Beatty, BG ;
Bryant, R ;
Wang, WC ;
Ashikaga, T ;
Gibson, PC ;
Leiman, G ;
Weaver, DL .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2004, 122 (02) :246-255
[2]   Estimation of hormone receptor status in fine-needle aspirates and paraffin-embedded sections from breast cancer using the novel rabbit monoclonal antibodies SP1 and SP2 [J].
Cano, G ;
Milanezi, F ;
Leitao, D ;
Ricardo, S ;
Brito, MJ ;
Schmitt, FC .
DIAGNOSTIC CYTOPATHOLOGY, 2003, 29 (04) :207-211
[3]   Validation of commonly used immunostains on cell-transferred cytologic specimens [J].
Elsheikh, TM ;
Corbin, K .
CANCER CYTOPATHOLOGY, 2006, 108 (02) :135-136
[4]   The effects of antibody clone and pretreatment method on the results of HER2 immunostaining in cytologic samples of metastatic breast cancer: A query and a review of the literature [J].
Fetsch, Patricia A. ;
Abati, Andrea .
DIAGNOSTIC CYTOPATHOLOGY, 2007, 35 (06) :319-328
[5]   Validation of commonly used immunostains on cell-transferred cytologic specimens [J].
Gong, Y ;
Joseph, T ;
Sneige, N .
CANCER CYTOPATHOLOGY, 2005, 105 (03) :158-164
[6]  
Hammond MEH, 2010, ARCH PATHOL LAB MED, V134, pE48, DOI 10.1043/1543-2165-134.7.e48
[7]   Immunohistochemical Detection of Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Expression in Breast Carcinomas Comparison on Cell Block, Needle-Core, and Tissue Block Preparations [J].
Hanley, Krisztina Z. ;
Birdsong, George G. ;
Cohen, Cynthia ;
Siddiqui, Momin T. .
CANCER CYTOPATHOLOGY, 2009, 117 (04) :279-288
[8]  
Hicks DG, 2008, ARCH PATHOL LAB MED, V132, P1008, DOI 10.1043/1543-2165(2008)132[1008:TAATFE]2.0.CO
[9]  
2
[10]   Standardized Assessment of the HER2 Status in Breast Cancer by Immunohistochemistry [J].
Hicks, David G. .
LABMEDICINE, 2011, 42 (08) :459-467